News

News
Partner news

Provention Bio Announces Closing of Upsized Initial Public Offering

Read full story
Partner news

Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA

Read full story
Partner news

Cue Health Completes $45MM Series B Financing

Read full story
Partner news

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story
Partner news

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story
Partner news

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story
Partner news

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story
Partner news

MGD011 Advances into Clinical Development

Read full story
Partner news

Protagonist Therapeutics Raises $40 Million Series C Financing

Read full story
Partner news

Accelerator Opens an NYC hub with $51 Million in Backing from Pfizer, J&J, Lilly

Read full story
Partner news

Minerva Neurosciences, Inc. Prices IPO below Range, Debuts at $6 per Share

Read full story
Partner news

ReVision Optics Closes $55 Million Financing

Read full story
Partner news

ViaCyte, Inc. Raises $10.6 Million in a Private Financing to Support Clinical Development of its Cell Therapy Product for Insulin Dependent Diabetes

Read full story
Partner news

Celladon Corporation Receives Patent from United States Patent and Trademark Office

Read full story
Partner news

SuperGen Completes Acquisition of Astex Therapeutics

Read full story